ID   NCC-SS1-C1
AC   CVCL_VG70
SY   NCCSS1C1
DR   DepMap; ACH-002789
DR   Wikidata; Q54907633
RX   PubMed=29450702;
WW   https://en.cellline.jp/product/ncc-ss1-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 41 hours (PubMed=29450702).
CC   Sequence variation: Gene fusion; HGNC; 11340; SS18 + HGNC; 11335; SSX1; Name(s)=SS18-SSX1 (PubMed=29450702).
CC   Omics: Deep proteome analysis.
ST   Source(s): PubMed=29450702
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 13
ST   D21S11: 32.2,33
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 10
//
RX   PubMed=29450702; DOI=10.1007/s13577-018-0199-9;
RA   Kito F., Oyama R., Takai Y., Sakumoto M., Shiozawa K., Qiao Z.-W.,
RA   Uehara T., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of the NCC-SS1-C1 synovial sarcoma
RT   cell line.";
RL   Hum. Cell 31:167-174(2018).
//